Pemigatinib for previously treated, locally advanced or metastatic cholangiocarc
- This topic has 0 replies, 1 voice, and was last updated 4 years ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
Thanks to Elsevier Inc. for this piece.
Gavin
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.